×
Biosig Technologies Receivables 2012-2024 | BSGM
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Biosig Technologies receivables from 2012 to 2024. Receivables can be defined as the total amount of collectibles for a company
View More
Biosig Technologies Receivables 2012-2024 | BSGM
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Biosig Technologies receivables from 2012 to 2024. Receivables can be defined as the total amount of collectibles for a company
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$212.5B
Intuitive Surgical (ISRG)
$180.7B
Alcon (ALC)
$45.5B
Edwards Lifesciences (EW)
$40B
IQVIA Holdings (IQV)
$38.1B
IDEXX Laboratories (IDXX)
$33.9B
DexCom (DXCM)
$27.2B
Waters (WAT)
$23B
STERIS (STE)
$22.3B
SONOVA HOLDING (SONVY)
$22B
Hologic (HOLX)
$19.4B
Fresenius Medical Care AG KGaA (FMS)
$11.8B
Sysmex ADR (SSMXY)
$11.6B
Globus Medical (GMED)
$10.1B
Teleflex (TFX)
$9.6B
Penumbra (PEN)
$8.8B
Masimo (MASI)
$7.8B
Glaukos (GKOS)
$7.2B
PROCEPT BioRobotics (PRCT)
$5.1B
Integer Holdings (ITGR)
$4.2B
Inari Medical (NARI)
$2.9B
TransMedics (TMDX)
$2.9B
Veracyte (VCYT)
$2.7B
LivaNova (LIVN)
$2.7B
Nihon Kohden (NHNKY)
$2.6B
Elekta AB (EKTAY)
$2.3B
Tandem Diabetes Care (TNDM)
$2.2B
RxSight (RXST)
$1.9B
Integra LifeSciences Holdings (IART)
$1.9B
Alphatec Holdings (ATEC)
$1.2B